Title : Structure-activity relationship studies of indolin-2-one derivatives as vascular endothelial growth factor receptor inhibitors and anticancer agents.

Pub. Date : 2020 Dec

PMID : 32885522






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sunitinib is the first oral indolin-2-one derivative marketed as a VEGFR inhibitor in the treatment of renal cell carcinoma and gastrointestinal stromal tumors. Sunitinib kinase insert domain receptor Homo sapiens